Stock IMCR IMMUNOCORE HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Immunocore Holdings plc

Equities

IMCR

US45258D1054

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
58.46 USD +0.79% Intraday chart for Immunocore Holdings plc +4.99% -14.43%
03-21 Immunocore Holdings Files Mixed-Securities Shelf Registration MT
03-14 Transcript : Immunocore Holdings plc Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 09:30 AM

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Immunocore Holdings Files Mixed-Securities Shelf Registration
Immunocore Holdings' Q4 Net Loss Narrows, Revenue Rises
Immunocore Holdings plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Immunocore Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023
Immunocore Collaborates With Bristol Myers Squibb in Advanced Cutaneous Melanoma Trial
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday
Immunocore Plans $300 Million Convertible Senior Notes Offering ; Shares Fall After-Hours
Immunocore Holdings plc Provides Preliminary Unaudited Revenue Guidance for the Fourth Quarter and Full Year 2023
Immunocore Holdings Insider Sold Shares Worth $305,781, According to a Recent SEC Filing
Immunocore Plans to Boost Sales, Expand Access to Kimmtrak in 2024
Immunocore Holdings plc Announces the Addition of Two New Pre-Clinical Candidates for Autoimmune Diseases to Its Pipeline
Immunocore Holdings plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Immunocore's Q2 Net Loss Widens, Revenue Climbs
Immunocore Holdings plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Immunocore Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2023
Immunocore Holdings plc Announces Data Presented At the AARC 2023 Conference
Immunocore Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2022
Immunocore Holdings Q4 Loss Narrows on Higher Revenue
Immunocore Holdings plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
Immunocore Holdings plc Announces Initial Phase 1 Safety and Pharmacodynamic Activity Data with First Soluble TCR therapy for people living with HIV
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMCR Stock
  4. News Immunocore Holdings plc
  5. Other languages